Home/ Stocks/ CELU

Celularity Inc. Class A Common Stock

CELU XNAS

$0.99 -0.03 (-2.45%) ▼ 15-min delayed

Open

$1.05

High

$1.07

Low

$0.98

Volume

192.3K

Market Cap

$29.52M

About Celularity Inc. Class A Common Stock

Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 115 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$5.28M	$-23,076,000	$-0.88
Q2 2025	$5.74M	$-24,524,000	$-1.02
Q1 2025	$11.43M	$-19,754,000	$-0.84
FY 2024	$54.22M	$-57,892,000	$-2.64

Earnings & Analyst Ratings

Next Earnings: Thu, Aug 27, 2026

Calendar →

Related Market News

No specific coverage for CELU yet. Check out our latest market news or earnings calendar.

Get CELU Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Celularity Inc. Class A Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.